KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Non-cash Items (2021 - 2022)

AbCellera Biologics (ABCL) has disclosed Non-cash Items for 2 consecutive years, with $1.8 million as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Non-cash Items changed N/A year-over-year to $1.8 million, compared with a TTM value of $1.8 million through Dec 2022, changed N/A, and an annual FY2022 reading of $1.8 million, changed N/A over the prior year.
  • Non-cash Items was $1.8 million for Q4 2022 at AbCellera Biologics, down from $22.5 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $25.0 million in Q1 2021 and bottomed at $1.8 million in Q4 2022.